NewsBenzingaLe PDG de Teva Pharmaceutical Industries déclare que le médicament contre la schizophrénie Weltruza, tout juste lancé, ne générera pas de revenus significatifs avant le second semestre 2027, mais qu’il sera bien positionné pour 2028 ; malgré la... Le PDG de Teva Pharmaceutical Industries déclare que le médicament contre la schizophrénie Weltruza, tout juste lancé, ne générera pas de revenus significatifs avant le second semestre 2027, mais qu’il sera bien positionné pour 2028 ; malgré la... Benzinga 2026.11.03 14:59 (GMT+0) Open on Benzinga Other news Dan Ives Says ‘Clearly Jensen Wants to Come Back as CEO’, Sees Potential Special Shareholder Meeting Telsey Advisory Group Maintains Market Perform on Kohl's, Raises Price Target to $25 Red Cat Q3 Revenue Contracts 42% in Q3, Analysts Cut Price Targets Citigroup Maintains Neutral on Petrobras Brasileiro, Lowers Price Target to $18.5 Nike Executive Says 2028 Will Be ‘A Challenging Year Financially’; Co. Expects Adjusted EPS To Decline Modestly In Fiscal 2028 From Fiscal 2027 Levels Lake Street Maintains Buy on Envela, Lowers Price Target to $16
Nike Executive Says 2028 Will Be ‘A Challenging Year Financially’; Co. Expects Adjusted EPS To Decline Modestly In Fiscal 2028 From Fiscal 2027 Levels